[1] Saito Y, Robine JM, Crimmins EM. The methods and materials of health expectancy. Stat J IAOS 2014;30(3):209 − 23.
[2] World Health Organization. Evidence, policy, impact: WHO guide for evidence-informed decision-making. Geneva: World Health Organization; 2021.
[3] Lagiewka K. European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020. Arch Public Health 2012;70(1):23.
[4] Berger N, Van Oyen H, Cambois E, Fouweather T, Jagger C, Nusselder W, et al. Assessing the validity of the Global Activity Limitation Indicator in fourteen European countries. BMC Med Res Methodol 2015;15:1.
[5] Robine JM, Jagger C, Euro-REVES Group. Creating a coherent set of indicators to monitor health across Europe: the Euro-REVES 2 project. Eur J Public Health 2003;13(3 Suppl):6-14. http://dx.doi.org/10.1093/eurpub/13.suppl_1.6.
[6] van Oyen H, Van der Heyden J, Perenboom R, Jagger C. Monitoring population disability: evaluation of a new Global Activity Limitation Indicator (GALI). Soz Praventivmed 2006;51(3):153 − 61.
[7] Cabrero-García J, Juliá-Sanchis R. The Global Activity Limitation Index mainly measured functional disability, whereas self-rated health measured physical morbidity. J Clin Epidemiol 2014;67(4):468 − 76.
[8] Tarazona B, González-Enríquez J, Almazán-Isla J, Alcalde-Cabero E, de Pedro-Cuesta J, Galán I. Validity of the Global Activity Limitation Indicator (GALI) to evaluate severity of disability. Eur J Public Health 2021;31(3):539 − 40.
[9] Hsiao RL, Wu CH, Hsu CW, Saito Y, Lin YH. Validation of the global activity limitation indicator in Taiwan. BMC Med Res Methodol 2019;19(1):52.
[10] Cabrero-García J, Rico-Juan JR, Oliver-Roig A. Does the global activity limitation indicator measure participation restriction? Data from the European Health and Social Integration Survey in Spain. Qual Life Res 2022;31(5):1335 − 44.
[11] Hintzpeter B, Finger JD, Allen J, Kuhnert R, Seeling S, Thelen J, et al. European Health Interview Survey (EHIS) 2 – background and study methodology. J Health Monit 2019;4(4):66 − 79.
[12] Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. the index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914 − 9.
[13] Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983;31(12):721 − 7.
[14] Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res 2021;30(3):647 − 73.
[15] Luo N, Liu G, Li MH, Guan HJ, Jin XJ, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health 2017;20(4):662 − 9.
[16] Liu SW, Wu XL, Lopez AD, Wang LJ, Cai Y, Page A, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ 2016;94(1):46 − 57.
[17] Cai Y, Chen WQ, Wang XX, Xia X, Cui X, Wu SY, et al. Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008-2017. Chin J Cancer Res 2021;33(5):627 − 36.
[18] Berger N, Van der Heyden J, Van Oyen H. The global activity limitation indicator and self-rated health: two complementary predictors of mortality. Arch Public Health 2015;73(1):25.
[19] Ayuso-Álvarez A, Ortiz C, Fontán J, Rodríguez-Blázquez C, Damián J, López-Cuadrado T, et al. Predictive value of the Global Activity Limitation Indicator (GALI) on all-cause mortality. Public Health 2024;230:6 − 11.